ACHV · Achieve Life Sciences, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-29 | Waldman Reid Alexander |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest in substantially equal monthly installments over 36 months commencing May 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
47,250 |
| 2026-05-29 | Farrow Jeffrey S |
See Remarks |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest in substantially equal monthly installments over 36 months commencing May 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
47,250 |
| 2026-05-11 | Martin Christopher Nathan |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest in substantially equal monthly installments over 36 months commencing May 11, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
47,250 |
| 2026-04-18 | Goldberg Andrew D. |
Director |
Award↑
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the number of shares underlying the PRSU vest based on achievement of eight share price milestones ranging from 2x to 9x of a reference price, in whole or in part, upon achievement of certain financial performance conditions. The PRSUs are eligible for accelerated vesting pursuant to the Reporting Person's employment agreement with the Issuer. |
Performance Restricted Stock Unit (PRSU)
|
11,706,270 |
| 2026-04-18 | Goldberg Andrew D. |
Director |
Award↑
Filing footnotes — Restricted Stock Unit (RSU) (Direct)
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the RSU, the number of shares underlying the RSU vest as to 1/4 of the total award on the one-year anniversary of April 18, 2026, and thereafter in substantially equal quarterly installments on the twelve quarterly anniversaries thereafter, subject to the Reporting Person's provision of services to the Issuer on each vesting date. The RSUs are eligible for accelerated vesting pursuant to the Reporting Person's employment agreement with the Issuer. |
Restricted Stock Unit (RSU)
|
1,800,965 |
| 2026-04-18 | Goldberg Andrew D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest as to 1/4 of the total award on the one-year anniversary of April 18, 2026, and thereafter in substantially equal monthly installments over thirty-six months, subject to the Reporting Person's provision of services to the Issuer on each vesting date. The shares subject to the option are eligible for accelerated vesting pursuant to the Reporting Person's employment agreement with the Issuer. |
Stock Option (right to buy)
|
3,601,929 |
| 2026-01-28 | Oki Mark K |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
180,000 |
| 2026-01-28 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
645,000 |
| 2026-01-28 | Wan Jerry |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
70,300 |
| 2026-01-28 | Xinos Jaime |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
180,000 |
| 2026-01-28 | Donnelly Craig |
Chief Operations Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
180,000 |
| 2026-01-28 | Rubinstein Mark Lawrence |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
180,000 |
| 2025-12-04 | Atkisson Erik |
Chief Legal Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest as to 1/4 of the total award on the first anniversary of October 20, 2025, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
250,000 |
| 2025-10-01 | Donnelly Craig |
Chief Operations Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
This option will vest as to 1/4 of the total award on the first anniversary of September 8, 2025, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Stock Option (right to buy)
|
50,000 |
| 2025-09-18 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. |
Common Stock
|
297,500 |
| 2025-09-18 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit (PRSU)
|
140,000 |
| 2025-09-18 | Oki Mark K |
Chief Financial Officer |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit (PRSU)
|
168,000 |
| 2025-09-18 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $3.02 per share, inclusive. The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
129,501 |
| 2025-09-18 | Oki Mark K |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.83 to $3.02 per share, inclusive. The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
50,060 |
| 2025-09-18 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit (PRSU)
|
157,500 |
| 2025-09-18 | Oki Mark K |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. |
Common Stock
|
168,000 |
| 2025-09-04 | KING THOMAS BRAXTON |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. |
Common Stock
|
455,000 |
| 2025-09-04 | JACOBS CINDY |
President & CMO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
27,629 |
| 2025-09-04 | Wan Jerry |
Principal Accounting Officer |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit (PRSU)
|
24,500 |
| 2025-09-04 | Xinos Jaime |
Chief Commercial Officer |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit (PRSU)
|
49,000 |
| 2025-09-04 | Xinos Jaime |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
20,854 |
| 2025-09-04 | Xinos Jaime |
Chief Commercial Officer |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Performance Restricted Stock Unit (PRSU)
|
20,000 |
| 2025-09-04 | KING THOMAS BRAXTON |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
139,858 |
| 2025-09-04 | JACOBS CINDY |
President & CMO |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. |
Common Stock
|
110,000 |
| 2025-09-04 | Wan Jerry |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
14,070 |
| 2025-09-04 | JACOBS CINDY |
President & CMO |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit (PRSU)
|
84,000 |
| 2025-09-04 | KING THOMAS BRAXTON |
Director |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Represents PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit (PRSU)
|
455,000 |
| 2025-09-04 | Wan Jerry |
Principal Accounting Officer |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Performance Restricted Stock Unit (PRSU)
|
9,600 |
| 2025-09-04 | Wan Jerry |
Principal Accounting Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. |
Common Stock
|
34,100 |
| 2025-09-04 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Award↓
Filing footnotes — Performance Restricted Stock Unit (Direct)
Represent PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Commmittee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit
|
157,500 |
| 2025-09-04 | JACOBS CINDY |
President & CMO |
Convert↓
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Performance Restricted Stock Unit (PRSU)
|
26,000 |
| 2025-09-04 | Xinos Jaime |
Chief Commercial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. |
Common Stock
|
69,000 |
| 2025-09-04 | Oki Mark K |
Chief Financial Officer |
Award↓
Filing footnotes — Performance Restricted Stock Unit (Direct)
Represents performance restricted stock units ("PRSUs") previously reported on December 9, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit
|
168,000 |
| 2025-09-04 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Award↓
Filing footnotes — Performance Restricted Stock Unit (Direct)
Represent PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Commmittee of the Issuer's Board of Directors. Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
Performance Restricted Stock Unit
|
140,000 |
| 2025-06-06 | Martell Bridget A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. |
Stock Option (right to buy)
|
31,500 |
| 2025-06-06 | Duty Stuart |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. |
Stock Option (right to buy)
|
31,500 |
| 2025-06-06 | Phelan Nancy R. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. |
Stock Option (right to buy)
|
31,500 |
| 2025-06-06 | Slaoui Kristen B. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. |
Stock Option (right to buy)
|
31,500 |
| 2025-06-06 | KING THOMAS BRAXTON |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. |
Stock Option (right to buy)
|
31,500 |
| 2025-06-06 | Sellig Thomas |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders. |
Stock Option (right to buy)
|
31,500 |
| 2025-03-17 | Stewart Richard Alistair |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
In January 2025, pursuant to an agreement between the Reporting Person and the Issuer, the Reporting Person relinquished the stock option to purchase 67,500 shares of the Issuer's common stock granted on January 13, 2025. |
Common Stock
|
10,000 |
| 2025-03-17 | Oki Mark K |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.9387 per share, inclusive. The Rreporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
10,000 |
| 2025-01-28 | JACOBS CINDY |
President & CMO |
Award↑
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Performance Restricted Stock Unit (PRSU)
|
130,000 |
| 2025-01-28 | Wan Jerry |
Principal Accounting Officer |
Award↑
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Performance Restricted Stock Unit (PRSU)
|
48,000 |
| 2025-01-28 | Xinos Jaime |
Chief Commercial Officer |
Award↑
Filing footnotes — Performance Restricted Stock Unit (PRSU) (Direct)
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Performance Restricted Stock Unit (PRSU)
|
100,000 |